Anti-ERBB2 (clone 1.18.1) Recombinant Antibody Coupled Liposome (VS-1024-FY214) (CAT#: VS-1024-FY214)
Anti-HER2 antibody-conjugated liposomes have demonstrated significant potential in ovarian cancer research. Firstly, these liposomes can specifically target HER2-positive tumor cells, enhancing the selectivity and therapeutic efficacy of the drugs. Secondly, antibody-conjugated liposomes can effectively increase drug accumulation in the tumor microenvironment, thereby reducing side effects on normal tissues. Additionally, their mechanism of action may help overcome drug resistance, offering new treatment options for ovarian cancer patients.

(Immunofluorescent staining of human cell line U-251 MG shows localization to plasma membrane.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/1060/169_D12_1_selected.jpg

(Immunofluorescent staining of human cell line A-431 shows localization to plasma membrane.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/1338/if_selected.jpg

* Image credit: Human Protein Atlas v21.proteinatlas.org/images/1383/4682_B_5_1_val_selected.jpg

(Immunohistochemical staining of human rectum shows weak cytoplasmic positivity in glandular cells.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/43/ihc_selected.jpg

(Immunohistochemical staining of human urinary bladder shows moderate cytoplasmic and membranous positivity in urothelial cells.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/20416/ihc_selected.jpg

(Collecting ducts Staining: Low Intensity: Moderate Quantity: <25% Distal tubules Staining: Low Intensity: Moderate Quantity: <25%)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/43/1054_A_7_5.jpg

(Glandular cells Staining: Medium Intensity: Moderate Quantity: 75%-25% Location: Cytoplasmic/ membranous Myoepithelial cells Staining: Medium Intensity: Moderate Quantity: 75%-25% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/20416/45831_B_3_4.jpg

(Cell lines ordered by descending RNA expression order)
* Image credit: Human Protein Atlas v21.proteinatlas.org/ENSG00000141736-ERBB2
Specifications
- Potential Clinical Applications
- Ovarian cancer, Pancreatic cancer
Product Composition
- Clone
- 1.18.1
- Antibody Type
- IgG
- Antibody Host
- Human
- Antibody Reactivity
- Human
- Antibody Description
- This recombinant human monoclonal antibody has been specifically designed to bind to the HER2 protein, which plays a significant role in cell growth and differentiation. Overexpression of HER2 is often implicated in various aggressive forms of breast cancer, positioning the protein as a critical target for therapeutic intervention. By effectively targeting HER2, this antibody may contribute to the development of more effective treatment options for patients suffering from HER2-positive cancers.
Product Property
- Storage
- See in the COA
- Storage Shelf Time
- See in the COA
Target Information
- Target
- ERBB2
- Introduction
- This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized.
- Alternative Names
- NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2/neu
- Full Name
- Erb-B2 Receptor Tyrosine Kinase 2
- Gene ID
- 2064
- UniProt ID
- P04626
- Cellular Localization
- Cell membrane, Cell projection, Cytoplasm, Membrane, Nucleus
Recommended Products
Related Resources
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone 1.18.1"
See other products for "ERBB2"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
IAB-B008(A) | Recombinant Anti-human ERBB2 Intrabody [(D-Arg)9] | IF, FC, FuncS | scFv-(D-Arg)9 |
IAB-B008(G) | Recombinant Anti-human ERBB2 Intrabody [+36 GFP] | WB, ICC, FuncS | scFv-(+36GFP) |
IAB-B008(T) | Recombinant Anti-human ERBB2 Intrabody [Tat] | ICC, Neut, FuncS | scFv-Tat |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-1024-FY214. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: WB, FuncS, IF, Neut, ELISA, FC, IP
Application: FuncS, IF, Neut, ELISA, FC, IP, IHC
Application: FC, IP, ELISA, Neut, FuncS, IF, WB
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: ELISA, FC, FuncS
Application: ELISA, Inhib, FuncS
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.